Page 33 - 01.pdf

SEO Version

DIRECTORS’ REPORT
5.
Audit and Risk Management Committee (cont’d)
During the year, the ARMC met to review the scope of work of the auditors, and the results arising therefrom.
It followed up on outstanding matters contained in these reports, where appropriate.
The consolidated financial statements of the Group were reviewed by the ARMC prior to the submission to
the Directors of the Company for adoption. Further, the ARMC also reviewed the Group’s interim and annual
announcements and reports before they were submitted to the Board of Directors for approval.
The ARMC has recommended to the Board of Directors that Ernst & Young LLP, be nominated as auditors at
the forthcoming Annual General Meeting of the Company.
Further details regarding the ARMC are disclosed in the Statement of Corporate Governance.
6.
AsiaMedic Share Award Scheme
The Company has adopted a share award scheme known as the “AsiaMedic Share Award Scheme” (the
“Scheme”) pursuant to approval obtained from its shareholders at the extraordinary general meeting held on
30 April 2011. The purpose of the Scheme is to increase the Company’s flexibility and effectiveness in its
continuing efforts to reward, retain and motivate employees to achieve increased performance. The Scheme is
administered by the Remuneration Committee. No award has been granted since the adoption of the Scheme.
7.
Auditor
Ernst & Young LLP have expressed their willingness to accept reappointment as auditor.
On behalf of the Board of Directors:
Tan Wang Cheow
Director
Andi Solaiman
Director
Singapore
31 March 2014
ASIAMEDIC LIMITED
ANNUAL REPORT 2013
31